Market Overview

Australian Veterinary Healthcare Market to 2023 by Product, Animal, and Geography -


The "Australia
Veterinary Healthcare Market - Segmented by Product, Animal, Geography -
Growth, Trends, and Forecast (2018 - 2023)"
report has been
added to's offering.

The Australia Veterinary Healthcare market is expected to register a
CAGR of around 11% during the forecast period, 2018 to 2023.

Increasing Productivity at the Risk of Emerging Zoonosis

The growing meat consumption, especially of chicken and pork, is adding
to the exposure of dangerous foodborne pathogens. E. coli and Salmonella
infections cause serious diseases among people, and can even be fatal at
times, which is possible during the intensive production systems.

Moreover, there is a risk of emerging new strains of influenza viruses,
due to the long distance transportation of animals. The farms are often
in the same area, with a concentration of confined animals, which
potentially enhances the risk of avian influenza transferring to pigs.
The reassortment of the virus can lead to new strains and cause
infections among humans. Further, these farms increase the risk of
spreading and mixing of virus strains. Intensive farm practices are
causing the risk of emergence of these bacteria in the food, as stressed
animals become more susceptible to infection.

The risk from zoonotic diseases is fuelling the market for Australia
veterinary healthcare. Inter-Governmental Organizations and the food
production are making reforms to ensure health by the process of
surveillance and vaccination, investing in R&D, and transfer with
respect to vet health.

Additionally, advanced technology leading to innovations in animal
healthcare is also a factor responsible for the growth of Australia
veterinary healthcare market.

Key Highlights

  • Use of Counterfeit Medicines
  • The Vaccine Segment is Expected to Lead the Market

Developments in the Market

  • June 2018: Elanco Animal Health introduced New Respiratory PRRS
    Vaccine, a modified-live respiratory vaccine, which is effective in
    the reduction of porcine reproductive and respiratory syndrome (PRRS),
    respiratory form, in piglets two weeks or older.

Key Topics Covered

1. Introduction

2. Research Methodology

3. Executive Summary

4. Key Inferences

5. Market Overview

6. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)

7. Market Segmentation

8. Competitive Landscape

9. Key Players

10. Future of the Market

  • Bayer Healthcare
  • Boehringer Ingelheim
  • Ceva Animal Health Inc.
  • Elanco (Elli Lilly & Company)
  • Merck Animal Health
  • Virbac Corporation
  • Zoetis Animal Healthcare

For more information about this report visit

View Comments and Join the Discussion!